Literature DB >> 8476199

Effects of sodium ascorbate (vitamin C) and 2-methyl-1,4-naphthoquinone (vitamin K3) treatment on human tumor cell growth in vitro. II. Synergism with combined chemotherapy action.

W De Loecker1, J Janssens, J Bonte, H S Taper.   

Abstract

The growth inhibitory effects of a combined application of sodium ascorbate (Vitamin C) and 2-methyl-1,4-naphthoquinone (Vitamin K3) together with various chemotherapeutic agents has been examined on in vitro cultured human endometrial adenocarcinoma (AN3CA) cells. Combined vitamin treatment and chemotherapy in well defined conditions of cell confluence and at the dose levels applied result in a synergistic effect on growth inhibition. The combined vitamins when reaching their own synergistic cytotoxicity levels frequently obscure the additional synergistic effects attributable to the chemotherapeutic agents. Apart from the specific cytotoxic characteristics of the chemotherapeutic drugs examined, the formation of reactive oxygen radicals during treatment, possibly accentuated by less defined secondary mechanisms, appears essentially responsible for the observed stimulated cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8476199

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  alpha-Tocopheryl succinate promotes selective cell death induced by vitamin K3 in combination with ascorbate.

Authors:  M Tomasetti; E Strafella; S Staffolani; L Santarelli; J Neuzil; R Guerrieri
Journal:  Br J Cancer       Date:  2010-03-23       Impact factor: 7.640

Review 2.  The role of ascorbate in antioxidant protection of biomembranes: interaction with vitamin E and coenzyme Q.

Authors:  R E Beyer
Journal:  J Bioenerg Biomembr       Date:  1994-08       Impact factor: 2.945

3.  A 12 week, open label, phase I/IIa study using apatone for the treatment of prostate cancer patients who have failed standard therapy.

Authors:  Basir Tareen; Jack L Summers; James M Jamison; Deborah R Neal; Karen McGuire; Lowell Gerson; Ananias Diokno
Journal:  Int J Med Sci       Date:  2008-03-24       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.